Clinical Trials Logo

Citation(s)

  •   Gupta SR, Flaxel CJ
    The use of a vascular endothelial growth factor inhibitor (ranibizumab) in macular edema due to eales disease. Retin Cases Brief Rep. 2012 Winter;6(1):122-4. doi: 10.1097/ICB.0b013e31821608e8.

The Use of a VEGF Inhibitor (Lucentis) in Refractory Macular Edema Due to Eales' Disease

Details for clinical trial NCT00384449